Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Sichuan Da Xue Xue Bao. Yi Xue Ban = Journal of Sichuan University. Medical Science Edition|September 18, 2025
[YTHDF3 Regulates Macrophage Activation: Investigation of the Mechanisms Involved]Keren Peng, Qimin Yin, Jiyu Tong
European Journal of Medicinal Chemistry|October 25, 2022
Structural optimization of Imidazo[1, 2-a]pyridine derivatives for the treatment of gastric cancer via STAT3 signaling pathwayHuaxuan Li, Shumin Ouyang, Yi Zhang, et al.
Journal of Medicinal Chemistry|September 28, 2022
Boronic Acid: A Novel Pharmacophore Targeting Src Homology 2 (SH2) Domain of STAT3Lin Deng, Jianshan Mo, Yi Zhang, et al.
European Journal of Pharmacology|March 21, 2025
A novel adenosine 2A receptor antagonist HZ-086 enhances the efficiency of immunotherapy and alleviates the acquired resistance to PD-L1 by restoration of T cell functionsPengyan Wang, Wen Ding, Jianshan Mo, et al.
Nature Chemistry|March 3, 2026
Collective synthesis of 1,2,4-trisubstituted, meta- and ortho-substituted arene bioisosteres from bicyclobutanesFeng Wu, Ji-Jie Wang, Yuanjiu Xiao, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 18, 2024
Neuropeptide Precursor VGF Promotes Liver Metastatic Colonization of Gαq Mutant Uveal Melanoma by Facilitating Tumor Microenvironment via Paracrine LoopsShumin Ouyang, Shuo Shi, Wen Ding, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2025
Periostin-mediated NOTCH1 activation between tumor cells and HSCs crosstalk promotes liver metastasis of small cell lung cancerLinlin Lou, Keren Peng, Shumin Ouyang, et al.
JACS Au|January 30, 2026
PSMA-Targeting Chimeras for Cell-Type-Specific Degradation of Surface Immune Checkpoint Protein PD-L1Yuqing Luo, Xiaoxiao Gong, Keren Peng, et al.
Cell Death & Disease|October 6, 2025
The IGF2BP3-FASN axis drives lipid metabolic reprogramming to promote brain colonization in non-small cell lung cancerJingwei Li, Shumin Ouyang, Ziyou Lin, et al.
Cell Death & Disease|June 17, 2026
Targeting STAT3-mediated lipid metabolism reprogramming overcomes chemoresistance in acute myeloid leukemiaKeren Peng, Jianshan Mo, Zhenjiao Yang, et al.
Pageof 2